Angelini Ventures, the venture capital division of Angelini Industries, operates with a fund of 300 million euros. It invests in series C rounds, targeting biotech and health tech companies with check sizes ranging from 250,000 to 5 million euros. The firm has invested in companies like Nouscom and focuses on brain health and consumer segments, including women, children, and the elderly. Headquartered in Rome, Angelini Ventures has a global presence with team members from Europe, Asia, and the US.
